Bezos, Elon Musk and Zuckerberg Betting Big on S.C.G.
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More
Peter Maag Insider Alerts

Get notified the next time Peter Maag buys or sells CareDx stock. Enter your email address below to get our daily insider buying and selling report.

Peter Maag Insider Information

Insider of CareDx

Peter Maag is the executive chairman and CEO of CareDx, a biotechnology company. 

Maag first joined CareDx in 2012 as its president and CEO, a position he held until 2020. In January 2020, he was named chairman of the board, taking on the role of executive chairman in November 2020. 

Prior to CareDx, Maag spent a decade with Novartis, beginning as the company’s head of strategy in 2001. During his tenure, Maag helped spearhead new ventures in the company’s molecular diagnostics, along with heading up the expansion of Novartis’ blood screening business worldwide. His most recent position with the company was as president of diagnostics from 2009 to 2012, but he also worked as Novartis’ country president in Germany and Korea. 

Maag began his career in the pharmaceutical and diagnostic industry as an associate principal with McKinsey & Co from 1994 to 2001, working in Berlin and New Jersey on globalization and pharmaceutical strategies. 

Maag currently serves as a board member for PHOENIX Group (Mannaheim) and MolecularMD. He studied pharmaceutical sciences at both the University of London and the University of Heidelberg and received his Ph.D. from the University of Berlin, Germany.

What is Peter Maag's net worth?

The estimated net worth of Peter Maag is at least $13.19 million as of August 5th, 2021. Dr. Maag owns 356,202 shares of CareDx stock worth more than $13,190,160 as of January 22nd. This net worth approximation does not reflect any other investments that Dr. Maag may own. Learn More.

What is Peter Maag's salary?

As the Insider of CareDx, Inc, Dr. Maag earned a total compensation package of $6,400,015.00 in 2020. Dr. Maag earned a salary of $488,700.00, stock awards of $3,327,600.00, options awards of $1,721,935.00, non-equity compensation of $860,220.00, and other compensation of $1,560.00.

How do I contact Peter Maag?

The corporate mailing address for Dr. Maag and other CareDx executives is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. CareDx can also be reached via phone at (415) 287-2300 and via email at [email protected]

Has Peter Maag been buying or selling shares of CareDx?

In the last ninety days, Peter Maag has sold $444,500.00 of CareDx stock. Most recently, Peter Maag sold 10,000 shares of the business's stock in a transaction on Wednesday, January 5th. The shares were sold at an average price of $44.45, for a transaction totalling $444,500.00.

Who are CareDx's active insiders?

CareDx's insider roster includes Paul Adler (CEO), George Bickerstaff, III (Director), Michael Goldberg (Director), William Hagstrom (Director), Sasha King (CMO), Peter Maag (Insider), Reginald Seeto (Insider), Ralph Snyderman (Director), and Thomas Thomas (Director).

Are insiders buying or selling shares of CareDx?

In the last twelve months, CareDx insiders bought shares 1 times. They purchased a total of 5,000 shares worth more than $211,700.00. In the last twelve months, insiders at the sold shares 37 times. They sold a total of 416,378 shares worth more than $25,658,229.05. The most recent insider tranaction occured on January, 18th when insider Reginald Seeto sold 1,719 shares worth more than $68,880.33. Insiders at CareDx own 4.6 % of the company.

Information on this page was last updated on 1/18/2022.

Peter Maag Insider Trading History at CareDx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2022Sell10,000$44.45$444,500.00View SEC Filing Icon  
12/6/2021Sell10,000$41.62$416,200.00View SEC Filing Icon  
11/5/2021Sell10,000$49.40$494,000.00View SEC Filing Icon  
10/5/2021Sell10,000$64.67$646,700.00View SEC Filing Icon  
9/7/2021Sell10,000$73.68$736,800.00View SEC Filing Icon  
8/5/2021Sell10,000$83.13$831,300.00356,202View SEC Filing Icon  
7/6/2021Sell10,000$90.70$907,000.00374,256View SEC Filing Icon  
6/24/2021Sell9,605$95.30$915,356.50372,258View SEC Filing Icon  
6/9/2021Sell2,522$90.00$226,980.00374,466View SEC Filing Icon  
6/7/2021Sell26,500$86.25$2,285,625.00393,977View SEC Filing Icon  
5/25/2021Sell10,000$80.59$805,900.00419,444View SEC Filing Icon  
5/10/2021Sell26,293$68.94$1,812,639.42412,757View SEC Filing Icon  
5/5/2021Sell10,000$73.32$733,200.00419,444View SEC Filing Icon  
5/3/2021Sell20,000$76.64$1,532,800.00420,343View SEC Filing Icon  
4/5/2021Sell10,000$72.40$724,000.00421,468View SEC Filing Icon  
3/5/2021Sell10,000$61.29$612,900.00View SEC Filing Icon  
2/5/2021Sell10,000$89.82$898,200.00View SEC Filing Icon  
1/5/2021Sell10,000$71.92$719,200.00431,974View SEC Filing Icon  
12/7/2020Sell10,000$66.37$663,700.00431,974View SEC Filing Icon  
11/5/2020Sell10,000$53.48$534,800.00427,689View SEC Filing Icon  
10/5/2020Sell10,000$42.11$421,100.00431,974View SEC Filing Icon  
9/30/2020Sell16,992$37.59$638,729.28438,966View SEC Filing Icon  
9/8/2020Sell10,000$31.68$316,800.00431,974View SEC Filing Icon  
8/5/2020Sell13,008$36.77$478,304.16425,134View SEC Filing Icon  
7/6/2020Sell10,000$34.21$342,100.00421,974View SEC Filing Icon  
6/30/2020Sell18,182$35.07$637,642.74View SEC Filing Icon  
6/9/2020Sell1,818$35.00$63,630.00389,499View SEC Filing Icon  
6/5/2020Sell50,000$32.58$1,629,000.00391,817View SEC Filing Icon  
5/19/2020Sell30,000$32.24$967,200.00459,909View SEC Filing Icon  
3/16/2020Sell10,000$17.39$173,900.00489,909View SEC Filing Icon  
2/18/2020Sell10,000$26.62$266,200.00451,909View SEC Filing Icon  
1/15/2020Sell10,000$23.13$231,300.00429,814View SEC Filing Icon  
8/6/2019Sell50,000$28.84$1,442,000.00379,049View SEC Filing Icon  
5/13/2019Sell80,000$31.11$2,488,800.00408,406View SEC Filing Icon  
3/11/2019Sell50,000$34.23$1,711,500.00458,406View SEC Filing Icon  
11/29/2018Sell100,000$28.53$2,853,000.00408,372View SEC Filing Icon  
11/13/2018Sell50,000$26.48$1,324,000.00389,747View SEC Filing Icon  
9/4/2018Sell15,000$23.10$346,500.00439,747View SEC Filing Icon  
3/27/2018Sell15,000$7.87$118,050.00272,037View SEC Filing Icon  
8/15/2017Buy600$1.82$1,092.00107,350View SEC Filing Icon  
6/1/2015Buy2,000$4.84$9,680.00View SEC Filing Icon  
See Full Table

Peter Maag Buying and Selling Activity at CareDx

This chart shows Peter Maag's buying and selling at CareDx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CareDx Company Overview

CareDx logo
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in South San Francisco, CA.
Read More

Today's Range

Now: $37.03
Low: $36.47
High: $38.50

50 Day Range

MA: $43.06
Low: $37.03
High: $47.50

2 Week Range

Now: $37.03
Low: $36.47
High: $96.88


1,020,688 shs

Average Volume

808,920 shs

Market Capitalization

$1.96 billion

P/E Ratio


Dividend Yield



Bezos, Elon Musk and Zuckerberg Betting Big on S.C.G.
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More